This drug targets both Akt and p70S6K. For information at the website of Exelixis, the manufacturer. click here.
XL418 is currently in a phase I trial for solid tumors. For trial information go to this link at clinicaltrials.gov As of August 2008 the trial had been suspended due to low levels of drug.